1. Home
  2. RDWR vs SPRY Comparison

RDWR vs SPRY Comparison

Compare RDWR & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radware Ltd.

RDWR

Radware Ltd.

HOLD

Current Price

$24.62

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$10.41

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDWR
SPRY
Founded
1996
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
RDWR
SPRY
Price
$24.62
$10.41
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$32.50
$35.00
AVG Volume (30 Days)
172.5K
1.7M
Earning Date
02-11-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
N/A
Revenue
$294,636,000.00
$142,772,000.00
Revenue This Year
$11.39
N/A
Revenue Next Year
$7.43
$126.72
P/E Ratio
$64.86
N/A
Revenue Growth
10.40
5459.66
52 Week Low
$18.46
$6.66
52 Week High
$31.57
$18.90

Technical Indicators

Market Signals
Indicator
RDWR
SPRY
Relative Strength Index (RSI) 57.86 44.68
Support Level $23.58 $10.02
Resistance Level $24.93 $11.93
Average True Range (ATR) 0.65 0.71
MACD 0.01 -0.21
Stochastic Oscillator 78.34 6.55

Price Performance

Historical Comparison
RDWR
SPRY

About RDWR Radware Ltd.

Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. It generates the majority of its revenue from the United States.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: